2017 Annual Meeting Presentations
2017 Presentations
Presentations are provided in PDF with author's permission. Use the links below to find the session you're looking for. Sessions and presentations will be added as permissions are provided. For presentations that are not provided contact IMPAACT Operations for contact information.
MDR-TB Training
Monday, 29 May 2017
Principles of TB Epidemiology in Children, Including Contact Investigation |
|
Anneke Hesseling | |
Screening, Diagnosis and Management of MDR-TB in Children | View | Watch | Simon Schaaf |
Adverse Effects of Existing Second-line and Novel Antituberculosis Drugs in Children with Multidrug-resistant Tuberculosis | View | Watch | Tony Garcia-Prats |
Approach to MDR-TB microbiology in children | View | Anne-Marie Demers | |
Respiratory Specimen Collection for TB Investigation | Watch | ||
CXR reading for IMPAACT | View | Watch | Simon Schaaf |
Pediatric ECG evaluation for MDR-TB trials | View | Watch | James Nielsen |
A5300/I2003/PHOENIx Preparatory Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial | View | Watch | Amita Gupta and Vanessa Rouzier |
IMPAACT Plenary 1
Tuesday, 30 May 2017
Moderators: Sharon Nachman, MD and James McIntyre, MD
Perspectives from the Office of AIDS Research | Maureen Goodenow, PhD |
State of the Network |
Sharon Nachman, MD |
Behavioral and Social Science in Biomedical HIV Research |
Michael Stirratt, PhD |
Adolescent Pregnancy and Retention on Antiretroviral Therapy | Elaine Abrams |
Challenges to Eliminating HIV Among Adolescents |
Mary Jane Rotheram, PhD |
Turning the Corner on the AIDS Pandemic: Refining the Science-Driven HIV Research Enterprise |
Carl Dieffenbach, PhD |
IMPAACT Plenary 2
Wednesday, 31 May 2017
Grace Aldrovandi, MD and James McIntyre, MD
Studies Toward Understanding the Role of Integrin a4b7 in HIV and SIV Transmission and Pathogenesis |
James Arthos, PhD |
Cytotoxic T-cell Responses and HIV Cure |
Brad Jones, PhD |
Long-acting Methods |
Raphael Landovitz, MD, Msc |
PROMISE Updates and Key Safety Findings
|
|
Statistical Issues in IMPAACT Studies |
Terence Fenton, EdD Grace Montepiedra, PhD |
Site Recognition Awards | James McIntyre, MD |
Adherence Working Group Meeting
Tuesday, 30 May 2017
Welcome, year in review and goals |
K. Rivet Amico Sybil Hosek |
Adherence Measurement and Support in IMPAACT Studies |
Pamela Murnane |
|
IMPAACT 2009: Feasibility, Acceptability and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Breast Feeding in Adolescents and Young Women |
Sybil Hosek |
IMPAACT 2017: Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed HIV-Infected Children and Adolescents |
Liz Lowenthal |
A5300B/IMPAACT 2003B – PHOENix MDR TB: Protecting Households on Exposure to Newly Diagnosed Index Multidrug-Resistant TB Patients |
Amita Gupta Anneke Hesseling |
Shahin Lockman Lameck Chinula |
Study Coordinators Meeting
Wednesday, 31 May 2017
Key Updates and Operational Updates |
IMPAACT Ops Representatives: |
IMPAACT Site Overviews
|
Sadaf Inamdar |
Tuberculosis Scientific Committee
Tuesday, 30 May
Anneke Hesseling |
Tuberculosis Prevention and Treatment Study Updates |
Amita Gupta |
|
Jyoti Mathad |
|
Anneke Hesseling |
|
Ethel Weld |
The Future of MDR-TB Treatment in Children |
SMaRT Kids, the Adult MDR-TB Trials Landscape and Moving Pediatric TB Trials Forward |
Tony Garcia-Prats |
Emerging Data on Delaminid Pharmacokinetics and Safety in Children with MDR-TB |
Jeffrey Hafkin |
Elin Svensson |
|
Marco Schito |
|
Quantification of Circulating Mtb Antigen Peptides for Rapid Diagnosis and Treatment Monitoring |
Tony Hu |
Jeff Tornheim |
Cure Scientific Committee
Wednesday, 31 May
Committee Updates P1115 Study Status Updates |
Deborah Persaud Ellen Chadwick |
Biomarkers of HIV persistence as predictors of HIV Rebound off ART | Robert Siliciano |
Is HIV-1 antibody a useful biomarker for cure studies? |
Katherine Luzuriaga |
Effect of very early ART and therapeutic vaccines on reservoir size and viral rebound in non-human primates |
Afam Okoye |
William Borkowsky |
|
Considerations for ART interruption in African infants participating in P1115 |
Mutsa Bwakura-Dangarembizi |
Complications and Co-Morbidities Scientific Committee
Wednesday, 31 May
Neurodevelopment and Mental Health |
Neurovirology of HIV Infection: New Directions for Clinical Research |
Avi Nath |
David Bearden |
|
Update on IMPAACT P1104s/ PROMISE (1077BF)/ Neurodevelopmental sub-study findings |
Michael Boivin |
Larry Brown |
|
Geri Donenberg |
Metabolic and Infectious Complications |
Elaine Urbina |
|
IMPAACT P1072 Secondary Analysis Results |
Adriana Weinberg |
Updates on RSV Studies: IMPAACT 2011, 2012, 2013 |
Betsy McFarland |
Treatment Scientific Committee
Thursday, 1 June
Welcome and Overview of Treatment Scientific Agenda |
Elaine Abrams Ted Ruel |
ART for Pregnant and Breastfeeding Women:
|
IMPAACT HIV Treatment Study Updates |
Lameck Chinula |
|
P1026s: Pharmacokinetic Properties of Antiretroviral Therapy During Pregnancy |
|
Tammy Meyers |
|
Adrie Bekker |
|
P1097: Raltegravir Pharmacokinetics and Safety in Neonates; and P1110: A Phase I Trial to Evaluate the Safety and Pharmacokinetics of Raltegravir in HIV-Exposed Infants at High Risk |
Diana Clarke |
Ellen Chadwick |
|
Ann Melvin |
|
Carolyn Bolton |
Prevention Scentific Committee
Thursday, 1 June
Prevention of Vertical Transmission of HIV |
Andrea Ciaranello |
Primary Prevention in Adolescents and Youth – ARV Strategies |
Study update for IMPAACT 2009: Feasibility, Acceptability and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Breast Feeding in Adolescents and Young Women |
Sybil Hosek |
Immune Strategies for HIV Prevention |
Study update for IMPAACT P1112: Phase I Study to Determine Safety and Pharmacokinetic Parameters of Subcutaneous VRC01, a Potent Anti-HIV Neutralizing Monoclonal Antibody, in HIV-1 Exposed Infants |
Coleen Cunningham |
|
Cassie Simonich |
Pre-Clinical Infant HIV Vaccine Studies in Non-Human Primates |
Kristina DeParis |
Safety and Immunogenicity of HIV Vaccines in Infants |
Giny Fouda |
